nach oben

Current Cardiology Reports

Erschienen in:

01.09.2023 | Invasive Electrophysiology and Pacing (EK Heist, Section Editor)

Insomnia and Cardiovascular Health: Exploring the Link Between Sleep Disorders and Cardiac Arrhythmias

verfasst von: Parjanya Bhatt, Vaishnavi Patel, Jatin Motwani, Udit Choubey, Ramsha Mahmood, Vasu Gupta, Rohit Jain

Erschienen in: Current Cardiology Reports | Ausgabe 10/2023

Einloggen, um Zugang zu erhalten

Abstract

Cardiovascular diseases (CVDs), driven by modern lifestyles, have increased, with atrial fibrillation (AF) being a major concern linked to heart failure and stroke. Insomnia affects a large population, especially younger individuals, males, and menopausal women, decreasing the quality of life and potentially causing autonomic disturbances and cardiac arrhythmias.

Purpose of Review

This review explores the link between insomnia and cardiac arrhythmias, particularly AF, and its impact on cardiovascular health and emphasizes the need to address insomnia in individuals with cardiac arrhythmias by tailored strategies for sleep management to improve their overall well-being.

Recent Findings

Recent findings emphasize maintaining a regular sleep schedule to lower AF and bradyarrhythmia risks. Better sleep scores correlate with reduced AF and bradyarrhythmia risks, while insomnia increases AF risk, particularly in those under 40 years of age. Studies underscore the potential impact of sleep management in reducing cardiovascular risks and highlight the importance of addressing sleep issues to improve cardiovascular health outcomes.

Summary

Our review presents compelling evidence connecting insomnia and AF. Improving sleep patterns and addressing sleep issues can reduce AF risk, benefiting cardiovascular health. A comprehensive approach for managing at-risk individuals with cardiac arrhythmias, considering co-existing conditions, can decrease long-term disease burden and expenses. Incorporating sleep assessments and interventions into cardiovascular risk management, especially for those with insomnia, is recommended. Further research is needed to fully comprehend the complex relationship between insomnia and cardiac arrhythmias.

Drake CL, Pillai V, Roth T. Stress and sleep reactivity: a prospective investigation of the stress-diathesis model of insomnia. Sleep. 2014;37(8):1295–304. https://doi.org/10.5665/sleep.3916. PMID: 25083009; PMCID: PMC4096198.CrossRefPubMedPubMedCentral

Drake CL, Cheng P, Almeida DM, Roth T. Familial risk for insomnia is associated with abnormal cortisol response to stress. Sleep. 2017;40(10):zsx143. https://doi.org/10.1093/sleep/zsx143. PMID: 28958055; PMCID: PMC5806584.

Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387–94. https://doi.org/10.1378/chest.14-0970.CrossRefPubMed

Bhaskar S, Hemavathy D, Prasad S. Prevalence of chronic insomnia in adult patients and its correlation with medical comorbidities. J Family Med Prim Care. 2016;5(4):780–4. https://doi.org/10.4103/2249-4863.201153.CrossRefPubMedPubMedCentral

Rosenberg R, Citrome L, Drake CL. Advances in the treatment of chronic insomnia: a narrative review of new nonpharmacologic and pharmacologic therapies. Neuropsychiatr Dis Treat. 2021;17:2549–2566. Published 2021 Aug 6. https://doi.org/10.2147/NDT.S297504.

Morin CM, Jarrin DC, Ivers H, Mérette C, LeBlanc M, Savard J. Incidence, persistence, and remission rates of insomnia over 5 years. JAMA Netw Open. 2020;3(11):e2018782. Published 2020 Nov 2. https://doi.org/10.1001/jamanetworkopen.2020.18782.

Bonnet M. Etiology of insomnia. Sleep Med. 2006;7(7):544. https://doi.org/10.1016/j.sleep.2006.05.012.CrossRefPubMed

Katz DA, McHorney CA. The relationship between insomnia and health-related quality of life in patients with chronic illness. J Fam Pract. 2002;51(3):229–35.PubMed

Andersson C, Vasan RS. Epidemiology of cardiovascular disease in young individuals. Nat Rev Cardiol. 2018;15(4):230–40. https://doi.org/10.1038/nrcardio.2017.154.CrossRefPubMed

10.

Sun J, Qiao Y, Zhao M, et al. Global, regional, and national burden of cardiovascular diseases in youths and young adults aged 15–39 years in 204 countries/territories, 1990–2019: A systematic analysis of Global Burden of Disease Study 2019. BMC Med. 2023;21:222. https://doi.org/10.1186/s12916-023-02925-4.CrossRefPubMedPubMedCentral

11.

Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MH. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837–47. https://doi.org/10.1161/CIRCULATIONAHA.113.005119.CrossRefPubMed

12.

Lechat B, Appleton S, Melaku YA, et al. Comorbid insomnia and sleep apnoea is associated with all-cause mortality. Eur Respir J. 2022;60(1):2101958. Published 2022 Jul 13. https://doi.org/10.1183/13993003.01958-2021.

13.

Krijthe BP, Kunst A, Benjamin EJ, Lip GYH, Franco OH, Hofman A, Witteman JC M, Stricker BH, Heeringa J. Projections on the number of individuals with atrial fibrillation in the European Union, from. to 2060. Eur Heart J. 2013;34(35):2746–51. https://doi.org/10.1093/eurheartj/eht280.CrossRef

14.

Hald EM, Løchen ML, Mathiesen EB, et al. Atrial fibrillation, venous thromboembolism, ischemic stroke, and all-cause mortality: the Tromsø study. Res Pract Thromb Haemost. 2020;4(6):1004–1012. Published 2020 Jul 6. https://doi.org/10.1002/rth2.12351.

15.

Fan YY. Effects of sleep deprivation on action potential and transient outward potassium current in ventricular myocytes in rats. Med Sci Monit. 2015;21:542–9. https://doi.org/10.12659/msm.893414.CrossRefPubMedPubMedCentral

16.

Roth T. Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med. 2007;3(5 Suppl):S7–10.CrossRefPubMedPubMedCentral

17.

Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97–111. https://doi.org/10.1053/smrv.2002.0186.CrossRefPubMed

18.

Harvey AG. A cognitive model of insomnia. Behav Res Ther. 2002;40(8):869–93. https://doi.org/10.1016/s0005-7967(01)00061-4.CrossRefPubMed

19.

Rodenbeck A, Hajak G. “Neuroendocrine dysregulation in primary insomnia.” Revue neurologique vol. 157,11 Pt 2. 2001:S57–61.

20.

Chokesuwattanaskul R, Thongprayoon C, Sharma K, Congrete S, Tanawuttiwat T, Cheungpasitporn W. Associations of sleep quality with incident atrial fibrillation: a meta-analysis. Intern Med J. 2018;48(8):964–72. https://doi.org/10.1111/imj.13764.CrossRefPubMed

21.

Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996;(3):354–81. PMID: 8737210.

22.

Cabiddu R, Cerutti S, Viardot G, Werner S, Bianchi AM. Modulation of the sympatho-vagal balance during sleep: frequency domain study of heart rate variability and respiration. Front Physiol. 2012;9(3):45. https://doi.org/10.3389/fphys.2012.00045. PMID: 22416233; PMCID: PMC3299415.CrossRef

23.

Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, Malouf JF, Ammash NM, Friedman PA, Somers VK. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004;110(4):364–7. https://doi.org/10.1161/01.CIR.0000136587.68725.8E. Epub 2004 Jul 12 PMID: 15249509.CrossRefPubMed

24.

Sari I, Davutoglu V, Ozbala B, Ozer O, Baltaci Y, Yavuz S, Aksoy M. Acute sleep deprivation is associated with increased electrocardiographic P-wave dispersion in healthy young men and women. Pacing Clin Electrophysiol. 2008;31(4):438–42. https://doi.org/10.1111/j.1540-8159.2008.01013.x. PMID: 18373762.CrossRefPubMed

25.

Esen Ö, Akçakoyun M, Açar G, Bulut M, Alızade E, Kargin R, Emıroğlu MY, Yazicioğlu MV, Gemici K, Esen AM. Acute sleep deprivation is associated with increased atrial electromechanical delay in healthy young adults. Pacing Clin Electrophysiol. 2011;34(12):1645–51. https://doi.org/10.1111/j.1540-8159.2011.03186.x. Epub 2011 Aug 11 PMID: 21834922.CrossRefPubMed

26.

Li J, Vitiello MV, Gooneratne NS. Sleep in normal aging. Sleep Med Clin. 2018;13(1):1–11. https://doi.org/10.1016/j.jsmc.2017.09.001.CrossRefPubMed

27.

Arand DL, Burton G, Bonnet MH. When to order a sleep study and how to read the report - Part I. Primary Care Reports. 2002;8:192.

28.

Arand DL, Burton G, Bonnet MH. When to order a sleep study and how to read the report - Part II. Primary Care Reports. 2002;8:200.

29.

Sutton EL. Insomnia. Ann Intern Med. 2021;174(3):ITC33-ITC48. https://doi.org/10.7326/AITC202103160.

30.

Irish LA, Kline CE, Gunn HE, Buysse DJ, Hall MH. The role of sleep hygiene in promoting public health: a review of empirical evidence. Sleep Med Rev. 2015;22:23–36. https://doi.org/10.1016/j.smrv.2014.10.001.CrossRefPubMed

31.

Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213. https://doi.org/10.1016/0165-1781(89)90047-4.CrossRefPubMed

32.

Klingman KJ, Jungquist CR, Perlis ML. Questionnaires that screen for multiple sleep disorders. Sleep Med Rev. 2017;32:37–44. https://doi.org/10.1016/j.smrv.2016.02.004.CrossRefPubMed

33.

Hauri P. Sleep hygiene. In: Hauri P, editor. Current concepts: the sleep disorders. The Upjohn Company; Kalamazoo, MI: 1977:21–35.

34.

Zarcone VP. Sleep hygiene. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 3rd ed. WB Saunders; Philadelphia, PA. 2000:657–61.

35.

Insomnia treatment: Cognitive behavioral therapy instead of Sleeping Pills. Mayo Clinic. 2023. Accessed July 11, 2023. https://www.mayoclinic.org/diseases-conditions/insomnia/in-depth/insomnia-treatment/art-20046677.

36.

Cognitive Behavioral Therapy for Insomnia (CBTI). Stanford Health Care (SHC) - Stanford Medical Center. Accessed July 11, 2023. https://stanfordhealthcare.org/medical-treatments/c/cognitive-behavioral-therapy-insomnia/procedures.html.

37.

• Rossman J. Cognitive-behavioral therapy for insomnia: an effective and underutilized treatment for insomnia. Am J Lifestyle Med. 2019;13(6):544–547. Published 2019 Aug 12. https://doi.org/10.1177/1559827619867677. This study highlights the prevalence of sleep difficulties and the effectiveness of cognitive-behavioral therapy for insomnia (CBT-i) as a nonpharmacological treatment. CBT-i is shown to be safe and highly effective, but underutilized due to the shortage of trained practitioners and patients’ tendency to learn about sleep medication instead. The authors advocate for physicians to recommend it as a first-line treatment for chronic insomnia.

38.

Sleep disorder (sedative-hypnotic) Drug Information. U.S. Food and Drug Administration. Accessed July 11, 2023. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/sleep-disorder-sedative-hypnotic-drug-information.

39.

•• Li X, Zhou T, Ma H, et al. Healthy sleep patterns and risk of incident arrhythmias. J Am Coll Cardiol. 2021;78(12):1197–207. https://doi.org/10.1016/j.jacc.2021.07.023. This prospective study highlights the importance of a healthy sleep pattern in reducing the risks of atrial fibrillation/flutter and bradyarrhythmia. The findings indicate that individuals with a healthier sleep score have a significantly lower risk of developing AF and bradyarrhythmia, independent of traditional risk factors, and the association is influenced by genetic susceptibility to AF. This study emphasizes the potential benefits of considering overall sleep behaviors in assessing cardiac arrhythmia risks.CrossRefPubMedPubMedCentral

40.

Han X, Yang Y, Chen Y, et al. Association between insomnia and atrial fibrillation in a Chinese population: a cross-sectional study. Clin Cardiol. 2017;40(9):765–9. https://doi.org/10.1002/clc.22731.CrossRefPubMedPubMedCentral

41.

Lee HH, Chen YC, Chen JJ, Lo SH, Guo YL, Hu HY. Insomnia and the risk of atrial fibrillation: a population-based cohort study. Acta Cardiol Sin. 2017;33(2):165–72. https://doi.org/10.6515/acs20160611b.CrossRefPubMedPubMedCentral

42.

•• Chen CC, Lin CH, Yang TY, et al. Association between sleep disorder and atrial fibrillation: a nationwide population-based cohort study. Sleep Med. 2022;96:50–6. https://doi.org/10.1016/j.sleep.2022.05.002. Important study revealing a strong link between sleep disorders (SDs) and atrial fibrillation (AF), with insomnia showing a higher impact on AF compared to other SDs. Emphasizes the need to address sleep disturbances for AF risk management.CrossRefPubMed

43.

Christensen MA, Dixit S, Dewland TA, et al. Sleep characteristics that predict atrial fibrillation. Heart Rhythm. 2018;15(9):1289–95. https://doi.org/10.1016/j.hrthm.2018.05.008.CrossRefPubMedPubMedCentral

44.

Bae NY, Lee SR, Choi EK, et al. Impact of mental disorders on the risk of atrial fibrillation in patients with diabetes mellitus: a nationwide population-based study. Cardiovasc Diabetol. 2022;21(1):251. Published 2022 Nov 17. https://doi.org/10.1186/s12933-022-01682-7.

Titel: Insomnia and Cardiovascular Health: Exploring the Link Between Sleep Disorders and Cardiac Arrhythmias
verfasst von: Parjanya Bhatt
Vaishnavi Patel
Jatin Motwani
Udit Choubey
Ramsha Mahmood
Vasu Gupta
Rohit Jain
Publikationsdatum: 01.09.2023
Verlag: Springer US
Erschienen in: Current Cardiology Reports / Ausgabe 10/2023
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-023-01939-x

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Insomnia and Cardiovascular Health: Exploring the Link Between Sleep Disorders and Cardiac Arrhythmias

Abstract

Purpose of Review

Recent Findings

Summary

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2023

Noninvasive Multimodality Imaging for the Assessment of Anomalous Coronary Artery

Correction to: Left Atrial Appendage Closure with Watchman vs Amulet Devices: Similarities and Differences

Update on Transcatheter Treatment of Mitral and Tricuspid Valve Regurgitation

Accurate Classification of Non-ischemic Cardiomyopathy

The Effect of EECP on Ischemic Heart Failure: a Systematic Review

The Emerging Role of Intracardiac Echocardiography (ICE) in Left Atrial Appendage Closure (LAAC)

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie